Lenvatinib: Remedy for renal cell carcinoma
Created 1 month ago by anniepery

FDA approved the medicine Lenvatinib to treat patients suffering from renal cell carcinoma, differentiated thyroid cancer, and hepatocellular carcinoma. Lenvatinib is a kinase inhibitor, inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). This medicine is available in capsules 4 mg and 10 mg. The active ingredient in the drug is Lenvatinib mesylate, and the inactive ingredients are Calcium Carbonate, Mannitol, Microcrystalline Cellulose, Hydroxypropyl Cellulose, Low-substituted Hydroxypropyl Cellulose, and Talc. Lenvatinib price in India is affordable, and one can buy this medicine from various pharmacies and suppliers. The Indian Pharma is the best supplier in supplying generic drugs of higher quality internationally. For best quality Lenvatinib medicine, call 18008891064.